As part of our ongoing aim to bring you interesting reports, we have added a summary of a review that outlined the importance of adhering and persisting with therapy for the long-term control of mild-to-moderate ulcerative colitis.
Independent commentary is provided by Associate Professor Robert Bryant, Head of the Inflammatory Bowel Disease service at the Queen Elizabeth Hospital and Research Lead at the Basil Hetzel Institute.
Please login below to download this issue (PDF)